Recce Pharmaceuticals advances global reach with Indonesia’s approval for Phase 3 Diabetic Foot Infection Trial
Recce Pharmaceuticals Ltd has secured approval for a Phase 3 trial on its treatment candidate to treat diabetic foot infections
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, CEO
James Graham
CEO
SPONSORED BY The Market Online